Malathion
- Generic Name
- Malathion
- Brand Names
- Ovide
- Drug Type
- Small Molecule
- Chemical Formula
- C10H19O6PS2
- CAS Number
- 121-75-5
- Unique Ingredient Identifier
- U5N7SU872W
- Background
Malathion is a parasympathomimetic organophosphate compound that is used as an insecticide for the treatment of head lice. Malathion is an irreversible cholinesterase inhibitor and has low human toxicity.
- Indication
For patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.
- Associated Conditions
- Head Lice Infestation
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
- Conditions
- ScabiesHead Lice
- Interventions
- First Posted Date
- 2017-08-01
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 118
- Registration Number
- NCT03236168
- Locations
- 🇸🇧
Atoifi Adventist Hospital, Atoifi, Malaita, Solomon Islands
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
- Conditions
- Pediculosis
- Interventions
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2014-06-13
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 403
- Registration Number
- NCT00963508
- Locations
- 🇺🇸
Investigator Site, San Antonio, Texas, United States
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2014-08-04
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 254
- Registration Number
- NCT00927472
- Locations
- 🇺🇸
Investigator Site, Jonesboro, Arkansas, United States
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
- Conditions
- Pediculosis
- Interventions
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2013-12-24
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00927407
- Locations
- 🇮🇳
Investigator Site, Rabale, Navi Mumbai, India
Ivermectin in the Treatment of Head Lice
- First Posted Date
- 2009-01-09
- Last Posted Date
- 2011-08-22
- Target Recruit Count
- 812
- Registration Number
- NCT00819520
- Locations
- 🇮🇱
Chaim Sheba Medical Centre, Tel Hashomer, Israel
🇬🇧Synexus Clinical Research Centre, Reading, Berks, United Kingdom
🇫🇷Hopital Avicenne, Bobigny, Paris, France
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
- Conditions
- Lice Infestations
- Interventions
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 360
- Registration Number
- NCT00244439
- Locations
- 🇺🇸
Investigator Site, Miamiville, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.